encainide has been researched along with Asystole in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, AH; Brooks, MM; Capone, R; Echt, DS; Greene, HL; Liebson, PR; Mitchell, LB; Peters, RW | 1 |
| Denes, P; Gillis, AM; Kammerling, JM; Pawitan, Y; Salerno, DM; Wilhelmsen, L | 1 |
| Akiyama, T; Greenberg, H; Kuo, CS; Pawitan, Y; Reynolds-Haertle, RA | 1 |
| Arensberg, D; Baker, A; Barker, AH; Echt, DS; Friedman, L; Greene, HL; Liebson, PR; Mitchell, LB; Obias-Manno, D; Peters, RW | 1 |
| Benson, DW; Fish, FA; Gillette, PC | 1 |
| Lemery, R; Nattel, S; Roy, D; Talajic, M; Theroux, P | 1 |
4 trial(s) available for encainide and Asystole
| Article | Year |
|---|---|
Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Circadian Rhythm; Death, Sudden, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Arrest; Humans; Moricizine; Sympathetic Nervous System | 1994 |
Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cross-Sectional Studies; Electric Countershock; Electrocardiography, Ambulatory; Encainide; Flecainide; Heart Arrest; Humans; Pre-Excitation Syndromes; Tachycardia | 1991 |
Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.
Topics: Cardiac Complexes, Premature; Cause of Death; Drug Combinations; Electrocardiography; Encainide; Female; Flecainide; Follow-Up Studies; Heart Arrest; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Placebos; Risk Factors; United States | 1991 |
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Topics: Actuarial Analysis; Anilides; Arrhythmias, Cardiac; Electrocardiography; Encainide; Flecainide; Follow-Up Studies; Heart Arrest; Heart Failure; Humans; Morbidity; Myocardial Infarction; Patient Compliance | 1991 |
2 other study(ies) available for encainide and Asystole
| Article | Year |
|---|---|
Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Death, Sudden; Encainide; Flecainide; Heart Arrest; Humans; Incidence; Retrospective Studies; Risk Factors; Tachycardia; Tachycardia, Supraventricular | 1991 |
Sinus node dysfunction and sudden cardiac death following treatment with encainide.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Death, Sudden; Electrocardiography; Electrophysiology; Encainide; Female; Heart Arrest; Humans; Middle Aged | 1989 |